TRACEE BLACKBURN: Open Payments
NPI 1396776498 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$49,600 in 230 payments from 20 companies in 2025. Trend: 2023 $39,846 · 2024 $58,054 · 2025 $49,600
Consulting: $17,027Speaker / faculty: $13,872Travel & lodging: $8,668Speaker / faculty: $5,343Food & beverage: $4,690
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 40 | $17,896 |
| Arcutis Biotherapeutics, Inc. | 42 | $17,090 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 32 | $9,150 |
| Janssen Biotech, Inc. | 18 | $1,785 |
| PFIZER INC. | 11 | $1,252 |
| ABBVIE INC. | 25 | $628 |
| Novartis Pharmaceuticals Corporation | 11 | $338 |
| Regeneron Healthcare Solutions, Inc. | 12 | $286 |
| Galderma Laboratories, L.P. | 10 | $262 |
| GENZYME CORPORATION | 6 | $198 |
Products named: Zoryve, EBGLYSS, ILUMYA, TREMFYA, LITFULO, Leqselvi, DUPIXENT, RINVOQ.
Industry payments across IL — which companies pay providers there.
